Penserra Capital Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-19,112
| Closed | -$2.23M | – | 1031 |
|
|
2025
Q1 | $2.23M | Buy |
+19,112
| New | +$2.23M | 0.04% | 288 |
|
|
2021
Q4 | – | Sell |
-865
| Closed | -$28K | – | 1379 |
|
|
2021
Q3 | $28K | Buy |
865
+10
| +1% | +$324 | ﹤0.01% | 1194 |
|
|
2021
Q2 | $57K | Buy |
855
+15
| +2% | +$1K | ﹤0.01% | 965 |
|
|
2021
Q1 | $47K | Sell |
840
-15
| -2% | -$839 | ﹤0.01% | 822 |
|
|
2020
Q4 | $69K | Buy |
855
+535
| +167% | +$43.2K | ﹤0.01% | 645 |
|
|
2020
Q3 | $22K | Buy |
+320
| New | +$22K | ﹤0.01% | 723 |
|